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Abstract 
Background. Exposure to intermittent hypoxia (IH) may enhance cardiac function and protects heart against 
ischemia-reperfusion (I/R) injury. To elucidate the underlying mechanisms, we developed a 
cardioprotective IH model that was characterized at hemodynamic, biochemical and molecular levels.  
Methods. Mice were exposed to 4 daily IH cycles (each composed of 2-min at 6-8% O2 followed by 3-min 
reoxygenation for 5 times) for 14 days, with normoxic mice as controls. Mice were then anesthetized and 
subdivided in various subgroups for analysis of contractility (pressure-volume loop), morphology, 
biochemistry or resistance to I/R (30-min occlusion of the left anterior descending coronary artery (LAD) 
followed by reperfusion and measurement of the area at risk and infarct size). In some mice, the 
phosphatidylinositide 3-kinase (PI3K) inhibitor wortmannin was administered (24 μg/kg ip) 15 min before 
LAD.  
Results. We found that IH did not induce myocardial hypertrophy; rather both contractility and cardiac 
function improved with greater number of capillaries per unit volume and greater expression of VEGF-R2, 
but not of VEGF. Besides increasing the phosphorylation of protein kinase B (Akt) and the endothelial 
isoform of NO synthase with respect to control, IH reduced the infarct size and post-LAD proteins 
carbonylation, index of oxidative damage. Administration of wortmannin reduced the level of Akt 
phosphorylation and worsened the infarct size.  
Conclusion. We conclude that the PI3K/Akt pathway is crucial for IH-induced cardioprotection and may 
represent a viable target to reduce myocardial I/R injury. 
Word count: 234 
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Introduction 
Ischemic preconditioning (IP), term used to identify the phenomenon whereby repeated exposures to sub-
lethal ischemia episodes enhance myocardial protection against potentially lethal ischemia [1], probably 
still represents the best tool for efficient prevention strategy against cardiovascular diseases. IP is 
composed of an immediate (hours) and a delayed (days) phase [2]. Whereas the first is caused by rapid 
posttranslational modification of existing proteins, the latter, also called “second window of protection” or 
SWOP, provides sustained protection as a result of persisting changes in the expression of proteins involved 
in protection [3]. Although IP is a potentially powerful and economic approach to reduce the burden of 
myocardial ischemia disease, several bottlenecks prevent its usability in humans. Exercise training is 
nevertheless a recognized strategy to induce delayed IP [4]. However, recommending exercise training is 
not a feasible option for some patients, including individuals with physical disabilities or exercise-intolerant 
patients, who may therefore be considered at high risk for cardiovascular diseases. Alternative non-invasive 
techniques to induce IP are therefore envisaged.  
A procedure that is gaining popularity among athletes because of promising results in terms of fitness and 
endurance gain, intermittent hypoxia (IH) is currently under scrutiny for prevention of cardiovascular 
diseases as well. IH was shown to increase exercise tolerance in elderly men with and without coronary 
artery disease [5] and to improve myocardial perfusion in coronary patients [6]. However the underlying 
mechanisms, which may be responsible for the marked dichotomy in the effects of IH on the cardiovascular 
system, remain elusive: besides representing a cardioprotective paradigm, IH is also associated to overt 
myocardial damage in patients suffering from obstructive sleep apnea (OSA). The protective vs. damaging 
effects of IH were examined elsewhere [7]: possibly the three-phase time-dependent effect modulated by 
GATA-4-dependent gene transcriptional regulation via inhibition of histone deacetylase play an important 
role [8]. But the characterization of the transformation of IH from a cardioprotective into an adverse factor 
is beyond the purposes of the present study, which mainly focuses into the cardioprotective effects of IH.  
Protein kinase B, or Akt, plays an important role in the phosphatidylinositide 3-kinase (PI3K) signaling 
pathway. When activated through translocation to the membrane and phosphorylation on either Thr-308 
or Ser-473, Akt stimulates a variety of targets and acts as a nodal regulatory kinase in myocardium [9], 
mainly with pro-survival, proliferative and protective effects. The purpose of this study is to develop a 
cardioprotective IH model to identify the underlying mechanisms at morphological, biochemical and 
molecular levels.  
To address cardioprotection, we adopted a validated method [10]. Angiogenesis was addressed by 
measuring the vascular endothelial growth factors (VEGFs), a family of glycoproteins involved in the 
regulation of vasculogenesis. The hypoxia-inducible factor (HIF)-1 stimulates VEGF expression by direct 
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transcriptional activation and through the PI3K/Akt signaling pathway [11]. VEGF binds to tyrosine kinase 
receptors (VEGF-Rs), one of which, VEGF-R2/flk-1, whose synthesis occurs through an autocrine mechanism 
[12], is known to mediate the majority of the cell responses to VEGF-A, the most important VEGF isoform. 
To address the effects of IH on the oxidative stress, we measured the expression of the inducible isoform of 
the major heat shock protein, HSP70, due to its known protective role during acute hypobaric hypoxia [13] 
and exercise training [14]. Wortmannin, a fungal metabolite that irreversibly binds and inhibits mammalian 
PI3K with an IC50 in the low nanomolar range, thereby preventing Akt phosphorylation [15], provides a 
unique way to test the involvement of the PI3K signaling pathway in this situation. 
Materials and methods 
Animal experiments were performed in accordance with the Swiss federal law and with the Guide for the 
Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 
85-23, revised 1996). The protocol was approved by the Committee of the Ethics of Animal Experiments of 
the Centre Hospitalier Universitaire Vaudoise (Permit Number 2262). All surgery was performed under 
ketamine-xylazine anesthesia and all efforts were made to minimize suffering. 
Experiments were conducted on 8-10-wk old male C57Bl6 mice (Charles River, France). Mice were fed 
standard diet without limitations until 24 h before sacrifice. Room temperature was kept at 21±2°C and 12 
h of light were alternated to 12 h of dark.  
Intermittent hypoxia protocol 
Mice were placed in gas-tight Plexiglas boxes (40x20x20 cm) equipped with a Clark-type O2 electrode and 
flushed with room air by means of a gas pump. A system of computer-assisted solenoid valves was 
operated to distribute air or N2 to the chamber. At the beginning of the IH events, the chambers were 
flushed with N2 for 3 min to achieve 6-8% O2 followed by 2 min air to restore 21% O2. Each cycle was 
repeated 5 times and each IH train was applied 4 times/day for 14 days (5 h 35 min between two successive 
IH trains, Figure 1). A total of 32 mice were exposed to IH, while 40 were maintained in control conditions 
(air in the place of N2). Three hours after the last IH train, mice were anesthetized by intraperitoneal 
injection of ketamine (150 mg/kg) plus xylazine (5 mg/kg), and randomly assigned to a group of tests. In 
additional control or IH mice (10/10), the PI3K inhibitor wortmannin was administered intraperitoneal (24 
µg/kg) 15 min before ischemia. 
Left ventricular Pressure-Volume (P-V) loops analyses 
Hemodynamic parameters were collected in 7/6 control/IH mice. The anesthetized mouse was placed in a 
supine position on a heating pad at 37.5°C. The trachea was cannulated and the animal attached to a 
positive-pressure volume controlled rodent ventilator (MiniVent, Hugo Sachs Elektronik, Harvard 
Apparatus, March-Hugstetten, Germany). The tidal volume and the ventilatory rate were set at 200-250 µl 
and 110-130 breaths/min, respectively. The right carotid artery was dissected and a Millar Mikro-Tip 
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conductance catheter (model SPR-839, tip size of 1.4F, Millar Instruments, Oxford, UK) introduced into the 
artery and advanced into the LV via the aortic valve [16]. Once steady-state hemodynamic was achieved, P-
V loops were recorded and processed using an MPVS Ultra system (Millar Instruments, Oxford, UK). The 
cuvette calibration method (Millar Instruments) was used to calculate the absolute volume data.  
LAD ligature  
Myocardial infarction was induced by regional left anterior descending (LAD) coronary artery occlusion in 
15/12 control/IH mice (5/5 of these were administered with wortmannin). After anesthesia, the trachea 
was cannulated and mice ventilated as described above. A left thoracotomy was performed between the 
4th and 5th rib and the heart was exposed to pass a 7-0 silk at 2-mm below the tip of the left auricle. The 
suture was tied using a shoestring knot over a 1-mm polyethylene tube (PE-10). After 30 min ischemia [17], 
the LAD was reopened for 3 h by pulling on the exteriorized suture to release the knot and the heart 
reperfused. Of all hearts subjected to this procedure, 8/5 control/IH hearts were used for the measurement 
of proteins carbonyl groups (see below), whereas 10/7 hearts were used to measure the area at risk and 
the infarct size.  
Area at risk and infarct size 
At the end of the reperfusion, the LAD was re-occluded and 5% Evans blue (250 µl) was injected into the 
left ventricle to mark the ischemic zone as tissue area without the blue dye. The heart was frozen in liquid 
N2 and stored at -20°C until analysis. To measure the infarct and risk areas, the heart was cut into five/six 1-
mm thick transverse slices from apex to base. The slices were incubated in 1% triphenyltetrazolium chloride 
in sodium phosphate buffer at 37°C for 20 min to stain viable cells in the risk zone. Afterwards, the slices 
were immersed in 10% formalin for 24 h to enhance contrast between stained and unstained areas, with 
the latter representing the infarct size. The extent of stained and unstained areas was calculated for each 
slice from computerized images using NIH Image software. The risk area is expressed as percentage of total 
ventricle area whereas the infarct area is expressed as a percentage of the risk area.  
Myocardial morphology 
For morphologic measurements in 4/4 control/IH freshly removed hearts, excess water was absorbed on 
paper, atria were excised and the ventricles plus the septum were weighed using a precision balance. In 
additional 5/4 control/IH mice, small fragments (<1 mm3) of the left ventricle tip were quickly fixed with 
2.5% glutaraldehyde in 0.1 M phosphate buffer, post-fixed with 1% OsO4 in the same buffer, dehydrated 
with alcohol, and embedded in araldite. Semi-thin sections stained with 1% toluidine blue in distilled water 
at 60°C, were used to evaluate the number of capillaries/mm2. For each heart, seventy-five non-
overlapping areas (800x magnification) were digitalized and analyzed making use of the Olympus BX51 
microscope with the Olympus C-3030 digital camera and the Cell^B software. The total surface evaluated 
per condition was 1.44 mm2. The number of capillaries was evaluated following the visual identification of 
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endothelial cells, as previously described [18]. Thin sections, stained with uranyl acetate and lead citrate, 
were observed with a transmission electron microscope (Philips CM10).  
Myocardial tissue analyses 
In 6/6 control/IH mice, freshly removed hearts were quickly rinsed in ice-cold PBS (pH 7.4), clamped 
between steel tongs pre-cooled with liquid N2 and stored at -80°C until analysis. For Akt assays, we also 
evaluated 5/5 control/IH mice treated with wortmannin. 
Western blot 
The expression level of target proteins was analyzed by Western blot technique. Frozen left ventricles were 
lysed in a buffer containing 10 mM TRIS-HCl, 50 mM KCl, 1 mM EDTA, 1% NONIDET P-40 and 3% Protease 
Inhibitor Cocktail (Sigma, St. Louis, MO, USA). Protein concentration was measured using either the Protein 
Assay or the Coomassie Blue kit (Bio-Rad Laboratories, Hercules, CA) according to manufacturer’s 
instructions. Equal amount of protein (40 µl) were separated on SDS-PAGE gel, electroblotted onto 
nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA). After blocking in Tris-Buffered Saline (TBS) 
containing 0.1% Tween-20 (TBS-T) and 5% of non-fat milk for 1 h at room temperature, membranes were 
probed overnight at 4°C with the following primary antibodies: rabbit polyclonal anti-VEGF-A (Calbiochem, 
Nottingham, UK); rabbit monoclonal anti-VEGF-R2 (Cell Signaling Technology, Danvers, MA); mouse 
monoclonal anti--actinin (Sigma, St. Louis, MO, USA); rabbit anti--tubulin (Santa Cruz Biothechnology); 
anti-Grp94 (clone 3C4 [19]); anti-Hsp70 (SPA-810, Stressgen); anti-HO-1 (OSA-110; Stressgen); anti-eNOS 
and P-eNOS (Ser1177) (Santa Cruz Biotechnology); anti-Akt and P-Akt Ser473 (Cell Signaling Technologies Abs); 
rabbit anti HIF-1 (Santa Cruz Biotechnology); and rabbit anti-Nrf2 (Santa Cruz Biotechnology). After 
washing three times with TBS-T, secondary antibodies were goat anti-mouse or goat anti-rabbit IgG (H+L) 
(Pierce, Rockford, IL), conjugated to horseradish peroxidase for 1 h at room temperature. Horseradish 
peroxidase reaction was detected using an enhanced chemiluminescent substrate, Super Signal West Dura 
Extended Duration (Pierce, Rockford, IL). Bands were scanned and their density quantified by means of 
BioRad GelDoc 2000 with reference to α-actinin or α- tubulin as loading controls. 
CHOP immunolocalization 
Double immunofluorescence was performed to visualize translocation of the CHOP transcription factor into 
cardiomyocyte nuclei. After fixation and permeabilization as described [19], cryosections were incubated 
for 1 h at room temperature with a mixture of rabbit polyclonal anti-CHOP antibodies (R-20 or F-168, Santa 
Cruz Biotech) and mouse monoclonal anti- sarcoglycan antibody (Monosan) to decorate cardiomyocyte 
sarcolemma. After adequate rinses, sections were incubated overnight at 4C with species-specific 
fluorescein and Texas Red conjugated secondary antibodies obtained in goat (Santa Cruz Biotech) and 
centrifuged before use to eliminate aggregates. Section were rinsed, mounted with buffered glycerol 
containing 4 g/ml DAPI and observed using the Zeiss Microscope Axioplan equipped with epifluorescence 
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optics. Images were acquired using a Leica digital DFC 300FX camera and the IM50 software (Leica 
Microsystems SRL, Milano, Italy).  Three to four micrographic fields were collected consistently from sub-
endocardial and sub-epicardial regions of each sample in order to evaluate at least 300 cardiomyocyte 
nuclei per section.  
Protein carbonyl groups 
In 8/5 control/IH mice we measured the amount of protein carbonyl groups. This analysis was also 
performed in 8/5 control/IH mice after LAD ligature and reperfusion. Pre- and post-LAD hearts were frozen 
in liquid N2 and protein carbonylation analyzed using the OxyBlot protein oxidation detection kit (Millipore) 
as previously described [20]. In brief, about 10 sections (12 m thickness) were cut transversally from the 
left ventricle wall. About 12 g protein was used for derivatization with DNPH. The degree of protein 
carbonylation was determined after normalization with the amount of loaded proteins, evaluated by 
densitometry of the Ponceau Red staining.  
Statistics 
Data are expressed as meanSEM. Significance level was P=0.05 (two-tailed). To detect differences among 
the groups, we routinely perform one-way ANOVA followed by the Neuman-Keuls post-test. When two 
groups are compared, this test reduces to the Student’s t-test.   
Results 
Intermittent hypoxia improves myocardial contractility 
IH mice showed a modest albeit significant decrease in body weight compared to control (Table 1). As heart 
weight also decreased in IH, the heart/body weight ratio was the same in the two groups, indicating lack of 
cardiac hypertrophy. Hematological parameters were maintained in all groups (not shown). Hemodynamic 
data and the pressure-volume loop curves measured in control and intermittent anesthetized mice (Figure 
2) show that exposure to IH did not affect neither the end-systolic nor the end-diastolic volumes. Likewise, 
the end-diastolic pressure was only marginally reduced by IH with a significant increase in end-systolic 
pressure respect to control. IH also induced a significant increase and decrease in maximum and minimum 
derivative pressures, respectively, compared to control. As a final result, the cardiac output increased from 
2437, SE 233 to 3345, SE 528 μl/min (P=0.03), e.g. a 27% increase, indicative of markedly improved 
myocardial performance as an outcome of the IH treatment.  
Intermittent hypoxia induces neo-angiogenesis through VEGF-R2 signaling 
Toluidine-blue staining shows a marked increase in the number of endothelial cells per unit area in IH with 
respect to control (Figure 3A), indicative of neo-angiogenesis. The average capillary count per unit area 
increased markedly in left ventricles from IH mice with respect to control (P=0.03, Figure 3B-C). Likewise, 
the expression of the vascular endothelial growth factor (VEGF) receptor 2 (VEGF-R2, also known as 
KDR/Flk-1) was increased in IH vs. control hearts (P=0.009). Whereas the protein expression of 42 kDa 
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isoform of VEGF (VEGF42, i.e., the soluble fraction) was unaffected by IH, the 55 kDa isoform (VEGF55, i.e., 
the membrane-bound fraction) was slightly over-expressed, but without statistical significance (P=0.07, 
Figure 3B-C). Transmission electron microscopy (Figure 3D-E) further supports increased capillary count in 
IH hearts. The progressive appearance of a cellular “bridge” is visible: pericytes appear to be involved in the 
formation of an intercapillary pillar. Junctional complexes are formed between opposite pericyte walls. In 
panel E, pillar size is similar to that in D. The merging of the lateral walls has completed the “bridge” 
structure.  
Intermittent hypoxia slightly enhances the oxidative stress 
IH increased the protein expression of heme oxygenase-1 (HO-1, Figure 4A, C). This increase was blunted in 
mice treated with wortmannin, in analogy with the effect led by this PI3K inhibitor on Akt phosphorylation 
(see later). By contrast, the expression level of Heat Shock Protein 70 kDa (HSP-70) and glucose-regulated 
protein 94 (GRP94), stress-proteins that were demonstrated to be up-regulated by hypoxia [21,22], 
remained unchanged. The pro-apoptotic factor endoplasmic reticulum stress-induced transcription factor 
C/EBP homologous protein (CHOP) was decreased by IH , without any effect led by wortmannin.  
To assess whether HO-1 expression was increased consequently to an endoplasmic reticulum-stress 
response, a double immunofluorescence analysis was performed to investigate the nuclear localization of 
the transcription factor CHOP (Figure 4B). In control hearts, about half of cardiomyocyte nuclei, identified 
by means of a nuclear fluorescent stain and circumscribed by -sarcoglycan-positive sarcolemma, showed 
positive labeling for CHOP. This number appeared reduced in IH. To quantitatively assess this reduction, we 
considered 300 cardiomyocyte nuclei per heart in 5/5 control/IH hearts and measured the percentage of 
nuclei showing CHOP labeling (49.164.04%, and 38.002.00%, respectively, P=0.03). Thus cardiomyocyte 
nuclei with CHOP labeling were reduced by about one-third in IH. In mice treated with wortmannin, the 
percentage of nuclei showing CHOP labeling changed to 51.755.19%, and 35.334.07%, respectively (P=NS 
from non-treated mice), showing that the pattern was not affected by wortmannin (microphotographs not 
shown). 
Intermittent hypoxia potentiates PI3K-Akt signaling 
Whereas the expression of Akt was not affected by IH, P-Akt expression was roughly 2.5 times higher in IH 
hearts (Figure 5). The inhibitor wortmannin markedly reduced the expression of Akt and its 
phosphorylation in both control and IH hearts. The phosphorylation of the endothelial isoform of NO 
synthase (eNOS, or NOS3) is known to depend on the activity of Akt. In support of this, P-eNOS was 
markedly increased in IH but maintained in control hearts, whereas treatment with wortmannin blunted 
both eNOS expression and phosphorylation. The hypoxia-signaling path did not appear prominent and the 
expression level of HIF-1 was unchanged in control and IH hearts, and the treatment with wortmannin did 
not affect its expression. By contrast, IH increased the expression of the oxidative stress transducer nuclear 
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factor (erythroid-derived 2)-like 2 (Nrf2), and the treatment with wortmannin greatly reduced Nrf2 
expression both in control and IH hearts. 
Intermittent hypoxia-induced cardioprotection depends on Akt 
Figure 6A shows representative images taken in one control and one IH heart after staining myocardial 
tissues slices with triphenyltetrazolium chloride to mark the infarct and risk areas. Whereas the blue and 
white areas represent viable and necrotic tissues, respectively, the red+white area represents the area at 
risk. Figure 6B shows the averaged risk and infarct areas of all the hearts subjected to LAD occlusion and 
reperfusion. Both IH and wortmannin did not change the risk zone, indicating that the extent of the LAD 
ligature was the same in all the groups. However, the infarct area was markedly decreased in IH, indicating 
the occurrence of IH-induced cardioprotection. The presence of wortmannin, on the other hand, blunted 
the protective effect of IH. 
Cardioprotection was also evaluated by assessing the degree of protein carbonylation, an index of redox 
unbalance (Figure 6C). Normalized densitometry values (Oxy/RP) increased markedly in myocardial tissue 
of control hearts compared to IH, reflecting the occurrence of oxidative stress in control but not in IH 
(P<0.01) (Figure 6D). 
Discussion 
The IH protocol described here enabled hearts to improve performance, induce neo-angiogenesis, increase 
the expression of HO-1 and decrease that of CHOP, indicative of attenuated apoptosis induced by 
endoplasmic reticulum stress. By contrast, the myocardial diastolic function and the expression levels of 
HSP70 and GRP94 were not affected by IH, indicative of lack of major adverse events originated by excess 
oxidative stress. Likewise, the hypoxia signaling pathway did not appear to be altered by IH, as indicated by 
lack of changes in HIF-1. Nevertheless, Akt phosphorylation was markedly increased. Collectively, these 
effects led to two important hallmarks in cardiovascular protection. First, cardiac function was improved, in 
qualitative agreement with data obtained in healthy and transgenic (over-expression of tumor necrosis 
factor , which induces heart failure) rodent models [23]. Second, cardioprotection was ameliorated as 
from reduced infarct size after LAD ligature and reduced formation of protein carbonyl groups in response 
to LAD. The administration of the PI3K inhibitor wortmannin suppressed Akt phosphorylation and some of 
the downstream effects, including eNOS and Nrf2, leaving HIF-1 unaffected. The inhibition led by 
wortmannin on Nrf2 expression, and hence the link between PI3K activity and the regulation of anti-
oxidative proteins, has already been demonstrated [24]. Furthermore, wortmannin reversed the favorable 
effects led by IH in terms of infarct size reduction, indicating that the cardioprotection induced by IH 
appeared directly related to the IH-induced over-phosphorylation of Akt.  
The measurement of the infarct area following LAD occlusion/reperfusion is related to the functional 
recovery of Langendorff-perfused hearts after I/R [10]. The LAD occlusion challenged ≈40% of the left 
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ventricle in all groups, yet the infarct area at the end of the reperfusion was 50% of the risk area in 
control hearts, which reduced by half in IH hearts, as a result of effective cardioprotection. IH-induced 
cardioprotection was entirely reverted by previous administration of wortmannin. This outcome is in 
qualitative agreement with a study where IH was given by exposing rats to a single 4-h period of hypobaric 
hypoxia (barometric pressure=404 mmHg) each day for four weeks [25]. At odds with the present 
investigation, in that study rats did not experience any significant change in body mass nor improved 
baseline myocardial performance. Whereas those Authors focused into the post-conditioning-like effects 
led by IH addressing the role of mitochondria in generating sub-lethal doses of ROS early at the reperfusion 
after ischemia in Langendorff-perfused hearts [26], here we focus into the pre-conditioning effects of IH by 
addressing the role of a number of signaling pathways.  
IH and angiogenesis 
Administering IH for 14 days markedly increased the capillary network. Electron microscopy demonstrated 
the formation of intercapillary pillars, which supports the hypothesis that neo-angiogenesis occurred 
mostly by intussusceptive growth, also known as splitting angiogenesis. This modality of capillary growth is 
characterized by capillary bed expansion through formation of finger-like inter-endothelial protrusions, 
which give rise to transcapillary tissue pillars forming a transluminar bridge, and eventually generate new 
vascular segments [27]. The intussusceptive angiogenesis, typical of developmental processes, generally 
coexists with vascular sprouting, the alternative modality of angiogenesis which predominates in cancer 
tissues [28]. Notably, intussusceptive capillary growth is fast (minutes-hours) as it does not primarily need 
cell proliferation. It is believed that an extended capillary network increases the blood supply and provides 
alternative shunt circulation on vessel obstruction, thus contributing to cardioprotection. In the described 
IH frame, neo-angiogenesis was accompanied by increased VEGF-R2 protein expression, whereas VEGF 
proteins increase was of borderline statistical significance, in analogy with observations gathered in aerobic 
exercise-trained rats [18]. VEGF-A, perhaps the most important VEGF isoform because of its critical role in 
the development of embryonic vasculature, binds to either one of the VEGF-R isoforms, but the VEGF-
R2/flk-1 isoform is known to mediate the majority of cell responses to VEGF-A [29]. VEGF-A binding causes 
VEGF-R2 dimerization and activation through a pathway leading to PLC-γ activation, increase in cytoplasm 
Ca++, activation of protein kinase C and phosphorylation of at least two of the mitogen-activated protein 
kinases, e.g., extracellular signal-regulated kinases ERK1/2 and p38 [30], which then move to the nucleus 
where they participate to various transcriptional activities leading to cell proliferation and migration [31]. 
Of interest, an OSA-like IH paradigm increases VEGF immunoreactivity in the carotid body thereby 
enhancing carotid body chemosensory response to hypoxia [32].  
VEGF and VEGF-R2 are known downstream effectors of the hypoxia-inducible factor (HIF)-1α, the master 
regulator of O2 homeostasis. Although it is likely that the over-expression of pro-angiogenesis factors 
depend on the myocardium response to hypoxia, we were unable to document significant changes in HIF-
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1α protein expression, perhaps due to the short hypoxia times followed by reoxygenation, which blunts 
HIF-1α protein over-expression [33]. We can’t exclude, however, the occurrence of fast peaks in HIF-1α 
protein levels in the correspondence of the hypoxia bouts. Indeed HIF-1α is likely to play a critical role, 
because acute IH (6 min 6% O2 + 6 min 21% O2, 5 times) gave protection that was lost in Hif1
+/- mice [34]. 
Albeit short, HIF-1α transactivation may nevertheless activate the transcription of a number of growth 
factors related to angiogenesis, including VEGF and its receptors. In mice constitutively expressing HIF-1α, 
neo-angiogenesis is pivotal to reduce infarct size and attenuate cardiac dysfunction through VEGF-A protein 
expression in infarct and peri-infarct areas [35]. As a matter of fact, however, the role of HIF-1 appeared 
marginal in this study, because treatment of wortmannin suppressed the cardioprotective role of IH leaving 
HIF-1 unaffected. 
IH mice are exposed not only to short hypoxic events, but also to repetitive ROS bursts during the 
reoxygenation phase. Such bursts might up-regulate HIF-1 activity. For example, ROS activate PLC-γ 
signaling, thus increasing intracellular Ca++ and activating Ca++/calmodulin-dependent protein kinase 
(CaMK), which phosphorylates the HIF-1 co-activator p300 and promotes HIF-1α activation [36]. 
Moreover, CaMK and diacylglycerol induce the activity of PKC, which stimulates mTOR-dependent HIF-1α 
synthesis and inhibits its targeting to ubiquitin by inhibiting prolyl-hydroxylases [37]. Since the protection 
occurred after factors such as HIF-1 have presumably returned to baseline, protection is likely related 
more to morphological or persisting changes such as angiogenesis than to direct effects by HIF-1. 
Although the role of neo-angiogenesis in promoting cardioprotection is unquestionable, there is however 
evidence that other signaling pathways may have a pivotal role in IH-induced cardioprotection.  
IH and stress response 
The employed IH protocol is effective in increasing the expression of HO-1, a HIF-1 target [38]. However, 
IH does not affect the expression of the stress-proteins involved in the heat shock pathway or the ER-stress 
response, as demonstrated by lack of change in the amount of Hsp70 and Grp94. By contrast, IH reduces 
the expression of CHOP and increases that of Nrf2, a transcription factor that represents the primary 
defense against the cytotoxic effects of oxidative stress and increases the expression of several antioxidant 
enzymes. Furthermore, IH appeared to decrease CHOP in about half of cardiomyocytes. Although CHOP 
mRNA is not changed in hearts exposed to 5 h hypoxia (10 or 6.5%O2) [39], these findings might be 
explained with the evidence that CHOP expression and activation are selectively blunted after inhibition of 
prolyl-hydroxylases [40]. Prolyl-hydroxylases are inhibited by hypoxia and their inhibition increases the 
transcription factor Nrf2 [40], another positive regulator of HO-1 expression [38].  Since IH increases Nrf2 
levels at variance with chronic hypoxia [41], it is likely that IH generates an inhibition of prolyl-hydroxylases 
that reveals sufficient to reduce nuclear localization of CHOP and increase the expression of HO-1. The 
oxidative stress associated with IH plays a role in the development of increased cardiac ischemic tolerance. 
The infarct size-limiting mechanism of IH seems to involve the PKC-delta-dependent pathway but 
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apparently not the increased capacity of major antioxidant enzymes [42], and the transcriptional 
activation of HSP70. Increased Nrf2 levels seems to be crucial in the upregulation of HO-1, which has been 
reported to have the most antioxidant response elements on its promoter [43]. HO-1 activity also releases 
carbon monoxide, which increases the expression of cardioprotective and anti-apoptotic molecules [44]. 
A further consequence of decreased CHOP activation is the relatively low oxidative stress that accompanies 
LAD in IH compared to control hearts. Although the degree of protein carbonylation might simply reflect 
the size of the infarcted area, the possibility exists that the smaller size of the infarcts observed in IH hearts 
derives from decreased oxidative stress. Among its effects, CHOP positively regulates the expression of the 
potent ER oxidase Ero1alpha, leading to oxidative stress and apoptotic death [45]. It is therefore likely that 
the lower number of cardiomyocytes displaying nuclear CHOP localization in IH hearts represent a lesser 
source of oxidant production when ischemia disrupts ER function, since nuclear CHOP localization indicates 
the presence of a sustained ER-stress response [45]. 
IH-induced signaling pathways 
IH markedly activated Ser-473 Akt phosphorylation, which was blunted on administration of wortmannin, 
concomitantly with loss of IH-induced cardioprotection. This strongly suggests that the cardioprotection 
elicited by IH is mediated by the activation of the PI3K-Akt pathway. Hypoxia is not known as an Akt 
activator, but the reoxygenation after hypoxia enables cardiomyocytes to phosphorylate Akt [46] without 
affecting Akt expression [47]. As the reoxygenation of hypoxic tissue is associated to ROS bursts, ROS may 
act as triggers for Akt phosphorylation [48,49]. The link among P-Akt, hypoxia and cardioprotection is not 
universally acknowledged. In rats exposed to IH (12% O2, 8 h/day for 4 and 8 weeks) P-Akt decreases with 
increased apoptosis through both mitochondrial-dependent and Fas death receptor-dependent paths [50]. 
In cultured cardiomyocytes subjected to hypoxia and reoxygenation, induction of gene 33 mRNA and Gene 
33 protein reduces Akt signaling [51]. Both these examples refer to IH situations that resemble the OSA-like 
rather than the cardioprotective paradigm, which reinforces the idea that cardioprotective IH is associated 
to enhanced PI3K-Akt signaling. When IH is given for 4 h (40 s at 10% O2 followed by 20 s at 21% O2), the 
resulting cardioprotection, assessed in Langendorff-perfused hearts, is largely due to the signaling 
downstream PKC, p38 MAPK and ERK1/2 without involving the PI3K signaling [52].  
Several observations support a role for P-Akt to mediate cardioprotection, in addition to its known effect in 
hypertensive [53] and infarcted hearts [54]. A recognized factor that triggers hypoxic preconditioning [55], 
its blockade by the antagonist LY-294002 suppresses the cardioprotection induced by the reoxygenation of 
hypoxic hearts [47]. The cascade activated by Akt represents a common route in eliciting preconditioning, for 
example by activating the endothelial isoform of NO synthase [56] (see also figure 4) and the NO/cGMP 
pathway, as observed in hypoxic brain tissue [57]. The beneficial effect of Akt activation on cardioprotection 
is evident in chronic hypobaric IH (8 h/day, 25-30 exposures) [58]. The reactivation of Akt has also been 
recognized as a critical determinant of survival in post-hypoxic cardiomyocytes in culture [59]. By contrast, 
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in a minipig LAD model, the immunosuppressant tacrolimus, or FK-506 or fujimycin, a 23-membered 
macrolide lactone, was shown to limit infarct by suppressing the inflammatory response through down-
regulation of the Akt signaling pathways [60], but the same substance also up-regulates HO-1, which is at 
odds with our observations. Interestingly, in an OSA model where IH is not protective, Akt Ser473 
phosphorylation was found to be decreased [61], in agreement with present data. Akt activation may also 
provide protection via increased eNOS and augmented NO stores. In fact, the anti-hypertensive effect of IH 
in young spontaneously hypertensive rats is associated with prevention of endothelial dysfunction and with 
increased accumulation of NO stores in vascular walls due to augmented eNOS activity [62]. The ability of 
IH to increase eNOS is shared also in OSA-like models at the level of the carotid body [63]. Full 
understanding of the role of NO in IH, however, should include monitoring not only of the expression of 
Akt-activated eNOS, but also of transcriptionally-activated iNOS, which has been shown to play a key role in 
IH-induced delayed cardioprotection [64,65]. 
Conclusion 
IH treatment may represent an efficient and economic way to induce long-term preconditioning without 
use of drugs, and comparable to the protection induced by physical training. Here, we describe an IH 
protocol that enables hearts to improve performance, induce neo-angiogenesis and resist to I/R injury. We 
identified the PI3K-Akt signaling as a key path that mediates IH-induced cardioprotection. Such pre-
conditioning would not necessarily reduce the incidence of myocardial I/R injury, but would likely affect the 
severity of myocardial damage. 
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Table 1 
Animal data and characteristics (meanSE). *, p<0.05 (Student’s t-test) 
 Control Intermittent hypoxia 
 Mean SE n Mean SE n 
Body weight       
  initial, g 21.52 0.25 50 21.48 0.20 42 
  final, g 22.50 0.31 50 20.30 0.39* 42 
  change, g 0.98 0.21 50 -0.39 0.14* 42 
Heart       
   Heart weight, mg 98.1 4.1 7 87.0 1.2* 6 
   Heart/body weight, mg/g 4.50 0.12 7 4.23 0.08 6 
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Figure legends 
Figure 1. Scheme of the intermittent hypoxia protocol used in this study. FIO2: fraction of O2 in inspired air 
(%). 
Figure 2. Hemodynamic data. Panel A. Pressure-volume loops obtained in ten consecutive contractions in 
two representative mice from either group. Panel B. Some hemodynamic data (meanSEM) obtained in all 
the examined mice (n=7/6 control and intermittent hypoxia, respectively), * marks P<0.05 with respect to 
control, Student’s two-tailed t-test. The diastolic (clear) and systolic (shaded) volumes, systolic (clear) and 
diastolic (shaded) pressures, +dP/dtmax (shaded) and –dP/dtmax (clear), and the cardiac output (clear) are 
reported.  
Figure 3. Angiogenesis. Panel A. Representative semithin sections stained with toluidine-blue from the left 
ventricle of a control and an IH mouse. The arrows indicate endothelial cells. The horizontal bar represents 
10 µm. Panel B. Representative Western blots reporting the protein expression of VEGF-R2, VEGF55, 
VEGF42 as well as α-actinin (loading control). Panel C. Data related to angiogenesis as obtained in all 
available hearts (meanSEM, n=6/6 control and intermittent hypoxia, respectively), * marks P<0.05 with 
respect to control, Student’s two-tailed t-test. The capillary count per unit area, as well as the expression of 
VEGF-R2, VEGF isoforms VEGF42 and VEGF55 as normalized for -actinin (Western blot) are reported. 
Panels D and E. Transmission electron microscopy images of left ventricle sections from an IH mouse. In 
panel C, arrows (→) indicate endothelial junctions. In panel D, arrow heads (►) show a cellular “bridge” 
that partitions a pre-existing capillary in the process of neo-angiogenesis. Ca, capillary lumen; Ec, 
erythrocytes; Ej, endothelial junctional complexes; Pc, pericyte. The horizontal bar represents 0.25 µm. 
Figure 4. Stress proteins. Panel A. Sample Western blot images illustrating the protein expressions of HO-1, 
HSP70, GRP94 (referred to -actin). Panel B. Double immunofluorescence analysis to investigate the 
nuclear localization of the transcription factor CHOP. The left column shows representative staining using 
anti-CHOP antibodies (red fluorescence), whereas the middle column shows α−sarcoglycan antibodies 
(green fluorescence). Nuclei were counterstained with DAPI (blue fluorescence). Arrows indicate 
cardiomyocyte nuclei positive for CHOP staining, which appears pink when merged with DAPI (right 
column). The upper and lower rows report a sample control and intermittent hypoxia heart. Bar: 50 μm. 
Panel C. Quantification of stress proteins from densitometry analysis of Western blots and analysis of Panel 
B images in all available samples (meanSEM, n=6/6). *, P<0.05 with respect to control, Student’s two-
tailed t-test. This panel also shows the effect of wortmannin on the expression of HO-1 and CHOP (n=5/5). 
Figure 5. Signaling. Western blots of Akt, its phosphorylated isoform P-Akt, eNOS, its phosphorylated 
isoform P-eNOS, HIF-1 and Nrf2 in all available samples (meanSEM, n=6/6 and 5/5 without and with 
wortmannin, respectively). *, P<0.05 with respect to control, Student’s two-tailed t-test.  
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Figure 6. Cardioprotection. Panel A. Representative images taken in a control and a IH heart after 
staining myocardial tissues slices with triphenyltetrazolium chloride to mark the infarct and risk areas. 
Whereas the blue and white areas represent viable and necrotic tissues, respectively, the red+white area 
represents the area at risk. Panel B. Box-and-whisker plots from all the hearts subjected to LAD occlusion 
and reperfusion. The boxes represent the 2nd and 3rd quartiles of data, with the whisker delimiting the min-
max range. The “+” represents the mean (n=10/7 and 5/5 without and with wortmannin, respectively). The 
insets report the ANOVA values. Panel C. Left: Representative Oxyblot (Oxy) analysis. Right: Loading of the 
same nitrocellulose sheet as visualized by Red Ponceau (RP) staining. Panel D. Normalized densitometry 
values (Oxy/RP), index of protein carbonylation. *, P<0.05 with respect to control; $, P<0.05 with respect to 
PRE-LAD (ANOVA one-way test, followed by the Bonferroni multiple comparison procedure, two tailed, the 
inset reports the value of the ANOVA P, n=6/6 and 8/5, pre-LAD and post-LAD, respectively).  
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